Immunovant, Inc.
Industry: Life Sciences ・ $IMVT on Nasdaq
Insider Sale
+$98,931
-1.24%
Shares
Shares Volume: 4,105 Shares
Average Share Price: $24.1
INSIDER
Barnett Eva Renee
Chief Financial Officer (Officer)
reported on Jan 10 2025
traded on Jan 8 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 327,064 |
| PURCHASES/SALES 1Y | 0 / 11 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $140,222.12 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 0 / 55 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $173,402 |
| COMPANY PREVIOUS TRADES |